2
Volltext
4
Volltext
6
Cherney, David Z I, Dekkers, Claire C J, Barbour, Sean J, Cattran, Daniel, Abdul Gafor, Abdul Halim, Greasley, Peter J, Laverman, Gozewijn D, Lim, Soo Kun, Di Tanna, Gian Luca, Reich, Heather N, Vervloet, Marc G, Wong, Muh Geot, Gansevoort, Ron T, Heerspink, Hiddo J L
Veröffentlicht in: DIAMOND investigators , Cherney , D Z I , Dekkers , C C J , Barbour , S J , Cattran , D , Abdul Gafor , A H , Greasley , P J , Laverman , G D , Lim , S K , Di Tanna , G L , Reich , H N , Vervloet , M G , Wong , M G , Gansevoort , R T & Heerspink , H J L 2020 , ' Effects of the SGLT2 inhibitor dapagliflozin on proteinuria in non -diabetic patients with chronic kidney disease (DIAMOND) : a randomised, double-blind, crossover trial ' , Lancet Diabetes & Endocrinology , vol. 8 , no. 7 , pp. 582-593 . https://doi.org/10.1016/S2213-8587(20)30162-5;
2020
7
Dirikgil, Ebru, Jonker, Jacqueline T., Tas, Sander W., Verburgh, Cornelis A., Soonawala, Darius, Hak, A. Elisabeth, Remmelts, Hilde H.F., IJpelaar, Daphne, Laverman, Gozewijn D., Rutgers, Abraham, van Laar, Jacob M., Moen, Hein J.Bernelot, Verhoeven, Peter M.J., Rabelink, Ton J., Bos, Willem Jan W., Teng, Y. K.Onno
Veröffentlicht in: Arthritis Research & Collaboration Hub (ARCH) study group , Dirikgil , E , Jonker , J T , Tas , S W , Verburgh , C A , Soonawala , D , Hak , A E , Remmelts , H H F , IJpelaar , D , Laverman , G D , Rutgers , A , van Laar , J M , Moen , H J B , Verhoeven , P M J , Rabelink , T J , Bos , W J W & Teng , Y K O 2021 , ' Clinical Practice Audit on the Management of Antineutrophil Cytoplasmic Antibody–Associated Vasculitis in the Netherlands ' , Kidney International Reports , vol. 6 , no. 10 , pp. 2671-2678 . https://doi.org/10.1016/j.ekir.2021.08.002;
2021